Standard Dental Labs Acquires Dr. Tooth Dental Lab
The acquired business adds an estimated just over $800,000 in annualized revenue, not a forecast of calendar 2026 reported revenue.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Standard Dental Labs (TUTH) acquired substantially all operating assets of Dr. Tooth, effective October 2, 2026, expanding its dental laboratory customer base. The business also operates as Sheen Dental Laboratory and Hansen Incarnati. The asset purchase uses cash and SDL common stock, with performance conditions tied to retained customer revenue.
Management estimates the business adds just over $800,000 in annualized revenue, taking SDL’s estimated base from approximately $822,000 to more than $1.6 million. These operating estimates extended over 12 months are not a calendar 2026 revenue forecast.
SDL plans to move production outsourced to China to Sarasota and expects improved facility profitability as integration progresses. Management sees an opportunity to rebuild the acquired business to more than $1.1 million in annualized revenue, dependent on retaining accounts, recovering customers and successfully transitioning production.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major pointDr. Tooth operating assets acquired expand SDL’s customer base, effective October 2, 2026.
- Minor pointJust over $800,000 in estimated annualized revenue added, nearly doubling SDL’s estimated base to more than $1.6 million.
- Minor point. Forward-looking: it has not happened yet and may not happen.Sarasota production transfer planned would bring work currently outsourced to China into SDL’s Florida operations.
- Minor point. Forward-looking: it has not happened yet and may not happen.Sarasota facility profitability expected by SDL to improve as integration progresses.
- Minor point. Forward-looking: it has not happened yet and may not happen.More than $1.1 million in annualized revenue is management’s rebuilding objective for the acquired business.
Negative
- Major pointCash and SDL common stock consideration entails a cash outlay and dilution for existing shareholders.
- Minor pointPerformance conditions in the asset purchase are tied to retained customer revenue.
- Minor point. Forward-looking: it has not happened yet and may not happen.Revenue rebuilding objective depends on retaining accounts, recovering customers and successfully transitioning production.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Sheen Dental and Hansen Incarnati join SDL as the Company plans to bring outsourced production to Sarasota
TAMPA, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) (“SDL” or the “Company”) today announced the acquisition, effective October 2, 2026, of substantially all of the operating assets of Dr. Tooth, LLC, the dental laboratory business also known as Sheen Dental Laboratory and Hansen Incarnati. The acquisition expands SDL’s customer base and advances its strategy of consolidating Florida dental laboratories around regional production facilities.
Based on current operating levels, management estimates that the acquired business adds just over
SDL plans to move production for the acquired business to its Sarasota facility, bringing work currently outsourced to China into the Company’s Florida operations. Management believes domestic production can strengthen quality control and communication with dentists, help recover former customer relationships and increase utilization of the Sarasota facility. By adding volume to its existing production infrastructure, SDL expects the acquisition to improve the facility’s profitability as integration progresses.
Management, which will included the existing Dr. Tooth management team of Denis Thaxton and Gavin White, believes these changes create an opportunity to rebuild the acquired business to more than
“Our focus is to bring this work back to Florida and give dentists direct access to the people making their restorations,” said James D. Brooks, President and Chief Executive Officer of Standard Dental Labs Inc. “We are adding an established customer base to our Sarasota operation, where the additional production can improve the economics of the facility. We also see a clear opportunity to win back business by giving customers the domestic production and responsive service they want.”
The transaction was structured as an asset purchase with a combination of cash and SDL common stock, including performance conditions tied to retained customer revenue.
About Standard Dental Labs Inc
Standard Dental Labs Inc. is a Florida-focused dental laboratory company pursuing growth through acquisitions and investment in domestic production capabilities. SDL serves dental practices through its laboratory operations and is focused on digital workflows, quality and responsive service. Its common stock trades on the OTCQB under the symbol TUTH.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding anticipated revenue growth, future acquisitions, integration efforts, scalability, financing initiatives, operational synergies, and long-term shareholder value. Forward-looking statements generally can be identified by words such as “expects,” “intends,” “plans,” “believes,” “anticipates,” “will,” “may,” “continue,” and similar expressions.
These statements are based on current expectations, estimates, and assumptions that are subject to significant risks and uncertainties, many of which are beyond the Company’s control. Actual results may differ materially from those expressed or implied by such forward-looking statements due to a variety of factors, including integration risks, customer retention, operational performance, financing availability, regulatory considerations, market conditions, and other risks disclosed in the Company’s filings with the Securities and Exchange Commission and disclosures published through OTC Markets.
The Company’s Regulation A offering statement referenced herein does not constitute an offer to sell or the solicitation of an offer to buy securities except pursuant to the qualified offering circular. Any investment should be made only after careful review of the offering materials and risk factors contained therein.
Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date made. Standard Dental Labs Inc. undertakes no obligation to update or revise forward-looking statements except as required by law.
Investor and Media Contact
Standard Dental Labs Inc.
424 E Central Blvd, Suite 308, Orlando, FL 32801
Phone: (407) 789-1923
Email: info@sdl.care
Investors: https://sdl.care/investors
SOURCE: Standard Dental Labs Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Standard Dental Labs acquire in the Dr. Tooth transaction?
Standard Dental Labs acquired substantially all operating assets of Dr. Tooth, effective October 2, 2026. The dental laboratory business also operates as Sheen Dental Laboratory and Hansen Incarnati. Consideration combines cash and SDL common stock, with performance conditions tied to retained customer revenue.
How much annualized revenue does the Dr. Tooth acquisition add to TUTH?
Management estimates Dr. Tooth adds just over $800,000 in annualized revenue, bringing SDL’s estimated annualized base to more than $1.6 million from approximately $822,000. These figures extend current operating activity over 12 months and are not a forecast of revenue to be reported for calendar 2026.